CLSD Clearside Biomedical Inc

Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye.

As of 10/03/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/02/2016
Outstanding shares:  60,190,731
Average volume:  133,468
Market cap:   $65,005,989
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BZ6VT37
Valuation   (See tab for details)
PE ratio:   820.03
PB ratio:   2.14
PS ratio:   2.50
Return on equity:   0.26%
Net income %:   0.32%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy